Bar On Insomnia Drug Would Be 'Pointless,' Teva Tells Court
Lawyers representing Teva Pharmaceuticals told a court on Tuesday it would be "pointless" to stop the company from selling a generic version of an insomnia drug before a patent expires in...To view the full article, register now.
Already a subscriber? Click here to view full article